RAPP ▲ +0.3% - Rapport Therapeutics, Inc.
$RAPP reported Q3 2026 EPS of -$0.84, beating the -$1.22 estimate by 31.1%. Revenue was $0. No analyst estimate was published for revenue.
04-NOV-2026 07:19 AM ET
Share this post
More filings for $RAPP
RAPP ▲ +0.3% - Rapport Therapeutics, Inc.Nov 4, 2026RAPP ▼ -0.6% - Rapport Therapeutics, Inc.Nov 3, 2026RAPP ▲ +3.8% - Rapport Therapeutics, Inc.Nov 2, 2026RAPP ▼ -20.1% - Rapport Therapeutics, Inc.Oct 28, 2026RAPP ▼ -20.1% - Rapport Therapeutics, Inc.Oct 28, 2026RAPP ▼ -8.6% - Rapport Therapeutics, Inc.Oct 27, 2026
View full $RAPP filing history →💬 Comments
Loading comments…
Leave a comment